Author

Benjamin Jones

Observed name: Benjamin N. Jones

Institution: Mirati Therapeutics (United States)

Observed institutions: Mirati Therapeutics (United States), University of Cincinnati

ORCID: 0009-0002-2982-9667

Observed ORCID: 0009-0002-2982-9667

OpenAlex ID: A5101994590

Discovery of TAK-659 an orally available investigational inhibitor of Spleen Tyrosine Kinase (SYK)

2016 · Betty Lam, Yasuyoshi Arikawa, et al. · Bioorganic & Medicinal Chemistry Letters · 62

Discovery of TAK-960: An orally available small molecule inhibitor of polo-like kinase 1 (PLK1)

2013 · Zhe Nie, Victoria Feher, et al. · Bioorganic & Medicinal Chemistry Letters · 50

Seleno-Auranofin (Et3PAuSe-tagl): Synthesis, Spectroscopic (EXAFS, 197Au Mössbauer, 31P, 1H, 13C, and 77Se NMR, ESI-MS) Characterization, Biological Activity, and Rapid Serum Albumin-Induced Triethylphosphine Oxide Generation

2010 · David T. Hill, Anvarhusein A. Isab, et al. · Inorganic Chemistry · 35

Discovery of Pyridopyrimidinones that Selectively Inhibit the H1047R PI3Kα Mutant Protein

2024 · John M. Ketcham, Stephen J. Harwood, et al. · Journal of Medicinal Chemistry · 27

Structure-based design and SAR development of 5,6-dihydroimidazolo[1,5-f]pteridine derivatives as novel Polo-like kinase-1 inhibitors

2016 · Andre Kiryanov, Srinivasa Natala, et al. · Bioorganic & Medicinal Chemistry Letters · 17

SAR of a novel ‘Anthranilamide Like’ series of VEGFR-2, multi protein kinase inhibitors for the treatment of cancer

2007 · Philip Wickens, Harold Kluender, et al. · Bioorganic & Medicinal Chemistry Letters · 15

Discovery of Five SOS2 Fragment Hits with Binding Modes Determined by SOS2 X-Ray Cocrystallography

2023 · Christopher R. Smith, Dan Chen, et al. · Journal of Medicinal Chemistry · 9

Stereoselective Amine Synthesis Mediated by a Zirconocene Hydride to Accelerate a Drug Discovery Program

2024 · Athenea N. Aloiau, Briana M. Bobek, et al. · The Journal of Organic Chemistry · 6

Author response for "Ligand-Centred Phenotype-Driven Development of Potent Kinase Inhibitors against Oesophageal Cancer"

2024 · Cecilia C. Ayala-Aguilera, Yang Ge, et al. · Publons reviews and discussion

Pyrrolotriazine derivatives useful for treating hyperproliferative disorders and diseases associated with angiogenesis

2007 · Dixon Julie A, Catherine A. Brennan, et al. · Europe PMC (PubMed Central)

Works count: 10

Citation count: 221

H-index: 7

I10-index: 6